Double-negative regulatory T cells: Non-conventional regulators

Immunologic Research

Volumn 35, Issue 1-2, 2006, Pages 163-177

  Thomson, Christopher W ^a   Lee, Boris P L ^a   Zhang, Li ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY HEALTH NETWORK   (Canada)

Author keywords

Cancer immunotherapy; Regulatory T cells; Suppression; Tolerance; Transplantation

Indexed keywords

CD3 ANTIGEN; CD4 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR2; CHEMOKINE RECEPTOR CCR3; CHEMOKINE RECEPTOR CXCR5; CYTOKINE; FAS ANTIGEN; FAS LIGAND; FC RECEPTOR; GAMMA INTERFERON; HLA A2 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MELAN A; PEPTIDE; PROTEIN KINASE LCK; PROTEIN LY6A; T LYMPHOCYTE RECEPTOR; T LYMPHOCYTE RECEPTOR ALPHA CHAIN; T LYMPHOCYTE RECEPTOR BETA CHAIN; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; AUTOIMMUNITY; CD4+ CD25+ T LYMPHOCYTE; CELL KILLING; COMPLEX FORMATION; DOWN REGULATION; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY;

EID: 33749607355     PISSN: 0257277X     EISSN: None     Source Type: Journal    
DOI: 10.1385/IR:35:1:163     Document Type: Review

References (89)

1. Sakaguchi S: Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. Annu Rev Immunol 2004;22: 531-562.
2. Mills KH: Regulatory T cells: friend or foe in immunity to infection? Nat Rev Immunol 2004;4:841-855.
3. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
4. Shevach EM: Regulatory T cells in autoimmmunity. Annu Rev Immunol 2000;18:423-449.
5. Sutmuller RP, van Duivenvoorde LM, van Elsas A, et al: Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J Exp Med 2001;194:823-832.
6. Young KJ, Kay LS, Phillips MJ, Zhang L: Antitumor activity mediated by double-negative T cells. Cancer Res 2003;63:8014-8021.
7. Singh B, Read S, Asseman C, et al: Control of intestinal inflammation by regulatory T cells. Immunol Rev 2001;182:190-200.
8. Akbari O, Stock P, DeKruyff RH, Umetsu DT: Role of regulatory T cells in allergy and asthma. Curr Opin Immunol 2003;15:627-633.
9. Edinger M, Hoffmann P, Ermann J, et al: CD4+CD25+ regulatory T cells preserve graft-versus-tumor activity while inhibiting graft-versus-host disease after bone marrow transplantation. Nat Med 2003;9:1144-1150.
10. Young KJ, DuTemple B, Phillips MJ, Zhang L: Inhibition of graft-versus-host disease by double-negative regulatory T cells. J Immunol 2003;171:134-141.
11. Bach JF: Regulatory T cells under scrutiny. Nat Rev Immunol 2003;3:189-198.
12. Shevach EM: CD4+ CD25+ suppressor T cells: more questions than answers. Nat Rev Immunol 2002;2: 389-400.
13. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003;299:1057-1061.
14. Najafian N, Chitnis T, Salama AD, et al: Regulatory functions of CD8+. J Clin Invest 2003;112:1037-1048.
15. Hayday A, Tigelaar R: Immunoregulation in the tissues by gammadelta T cells. Nat Rev Immunol 2003;3: 233-242.
16. Battaglia M, Roncarolo MG: The role of cytokines (and not only) in inducing and expanding T regulatory type 1 cells. Transplantation 2004;77:S16-S18.
17. Weiner HL: Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol Rev 2001;182:207-214.
18. Kronenberg, M: Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 2005;23:877-900.
19. George JF, Thomas JM: The molecular mechanisms of veto mediated regulation of alloresponsiveness. J Mol Med 1999;77:519-526.
20. Zhang ZX, Yang L, Young KJ, DuTemple B, Zhang L: Identification of a previously unknown antigen-specific regulatory T cell and its mechanism of suppression. Nat Med 2000;6:782-789.
21. Fischer K,Voelkl S, Heymann J, et al: Isolation and characterization of human antigen-specific TCR alpha beta+ CD4(-)CD8- double-negative regulatory T cells. Blood 2005;105:2828-2835.
22. Priatel JJ, Utting O, Teh HS: TCR/self-antigen interactions drive double-negative T cell peripheral expansion and differentiation into suppressor cells. J Immunol 2001;167:6188-6194.
23. Chen W, Ford MS,Young KJ, Cybulsky MI, Zhang L: Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003;170:1846-1853.
24. Chen W, Zhou D, Torrealba JR, Waddell TK, Grant D, Zhang L: Donor lymphocyte infusion induces long-term donor-specific cardiac xenograft survival through activation of recipient double-negative regulatory t cells. J Immunol 2005;175:3409-3416.
25. Ford MS,Young KJ, Zhang Z, Ohashi PS, Zhang L: The immune regulatory function of lymphoproliferative double negative T cells in vitro and in vivo. J Exp Med 2002;196:261-267.
26. Young KJ, Yang L, Phillips MJ, Zhang L: Donor-lymphocyte infusion induces transplantation tolerance by activating systemic and graft-infiltrating double-negative regulatory T cells. Blood 2002;100:3408-3414.
27. Pennington DJ, Silva-Santos B, Hayday AC: Gammadelta T cell development-having the strength to get there. Curr Opin Immunol 2005;17:108-115.
28. Wang R, Wang-Zhu Y, Grey H: Interactions between double positive thymocytes and high affinity ligands presented by cortical epithelial cells generate double negative thymocytes with T cell regulatory activity. Proc Natl Acad Sci USA 2002;99:2181-2186.
29. Marra LE, Zhang ZX, Joe B, et al: IL-10 induces regulatory T cell apoptosis by up-regulation of the membrane form of TNF-alpha. J Immunol 2004;172:1028-1035.
30. Landolfi MM, Van Houten N, Russell JQ, Scollay R, Parnes JR, Budd RC: CD2-CD4-CD8- lymph node T lymphocytes in MRL lpr/lpr mice are derived from a CD2+CD4+CD8+ thymic precursor. J Immunol 1993;151:1086-1096.
31. Takahama Y, Kosugi A, Singer A: Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage. J Immunol 1991;146:1134-1141.
32. Yamagiwa S, Sugahara S, Shimizu T, et al: The primary site of CD4- 8- B220+ alphabeta T cells in lpr mice: the appendix in normal mice. J Immunol 1998;160: 2665-2674.
33. Palathumpat V, Dejbakhsh-Jones S, Holm B, Strober S: Different subsets of T cells in the adult mouse bone marrow and spleen induce or suppress acute graft-versus-host disease. J Immunol 1992;149:808-817.
34. Ohteki T, Seki S, Abo T, Kumagai K: Liver is a possible site for the proliferation of abnormal CD3+4-8-double-negative lymphocytes in autoimmune MRL-lpr/lpr mice. J Exp Med 1990;172:7-12.
35. Kubota H, Okazaki H, Onuma M, Kano S, Hattori M, Minato N: CD3+4-8- alpha beta T cell population with biased T cell receptor V gene usage. Presence in bone marrow and possible involvement of IL-3 for their extrathymic development. J Immunol 1992;149:1143-1150.
36. Zhang ZX, Stanford WL, Zhang L: Ly-6A is critical for the function of double negative regulatory T cells. Eur J Immunol 2002;32:1584-1592.
37. Lee BP, Mansfield E, Hsieh SC, et al: Expression profiling of murine double-negative regulatory T cells suggest mechanisms for prolonged cardiac allograft survival. J Immunol 2005;174:4535-4544.
38. Takahashi T, Kuniyasu Y, Toda M, et al: Immunologic self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int Immunol 1998;10:1969-1980.
39. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998;188:287-296.
40. Young KJ, Zhang L: The nature and mechanisms of DN regulatory T-cell mediated suppression. Hum Immunol 2002;63:926-934.
41. Nishimura E, Sakihama T, Setoguchi R, Tanaka K, Sakaguchi S: Induction of antigen-specific immunologic tolerance by in vivo and in vitro antigen-specific expansion of naturally arising Foxp3+CD25+CD4+ regulatory T cells. Int Immunol 2004;16:1189-1201.
42. Furtado GC, Curotto de Lafaille MA, Kutchukhidze N, Lafaille JJ: Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J Exp Med 2002;196:851-857.
43. Groux H, O'Garra A, Bigler M, et al: A CD4+ T-scell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997;389:737-742.
44. Chen Y, Kuchroo VK, Inobe J, Hafler DA, Weiner HL: Regulatory T cell clones induced by oral tolerance: suppression of autoimmune encephalomyelitis. Science 1994;265:1237-1240.
45. van Twuyver E, Kast WM, Mooijaart RJ, Melief CJ, De Waal LP: Induction of transplantation tolerance by intravenous injection of allogeneic lymphocytes across an H-2 class II mismatch. Different mechanisms operate in tolerization across an H-2 class I vs. H-2 class II disparity. Eur J Immunol 1990;20:441-444.
46. Yang L, Du TB, Khan Q, Zhang L: Mechanisms of long-term donor-specific allograft survival induced by pre-transplant infusion of lymphocytes. Blood 1998;91: 324-330.
47. Chen W, Ford MS, Young KJ, Zhang L: Infusion of in vitro-generated DN T regulatory cells induces permanent cardiac allograft survival in mice. Transplant Proc 2003;35:2479-2480.
48. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995;155:1151-1164.
49. Viret C, Janeway CA, Jr: Self-sspecific MHC class II-restricted CD4-CD8- T cells that escape deletion and lack regulatory activity. J Immunol 2003;170:201-209.
50. Watanabe-Fukunaga R, Brannan CI, Copeland NG, Jenkins NA, Nagata S: Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 1992;356:314-317.
51. Benihoud K, Bonardelle D, Bobe P, Kiger N: MRL/lpr CD4- CD8- and CD8+ T cells, respectively, mediate Fas-dependent and perforin cytotoxic pathways. Eur J Immunol 1997;27:415-420.
52. Straus SE, Sneller M, Lenardo MJ, Puck JM, Strober W: An inherited disorder of lymphocyte apoptosis: the autoimmune lymphoproliferative syndrome. Ann Intern Med 1999;130:591-601.
53. Lenardo M, Chan KM, Hornung F, et al: Mature T lymphocyte apoptosis-immune regulation in a dynamic and unpredictable antigenic environment. Annu Rev Immunol 1999;17:221-253.
54. Martinez C, Marcos MA, de Alboran IM, et al: Functional double-negative T cells in the periphery express T cell receptor V beta gene products that cause deletion of single-positive T cells. Eur J Immunol 1993;23:250-254.
55. Zhou G, Drake CG, Levitsky HI: Amplification of tumor-specific regulatory T cells following therapeutic cancer vaccines. Blood 2006;107:628-636.
56. Li X, Ye DF, Xie X, Chen HZ, Lu WG: Proportion of CD4+CD25+ regulatory T cell is increased in the patients with ovarian carcinoma. Cancer Invest 2005;23:399-403.
57. Van Meirvenne S, Dullaers M, Heirman C, Straetman L, Michiels A, Thielemans K: In vivo depletion of CD4+CD25+ regulatory t cells enhances the antigen-specific primary and memory CTL response elicited by mature mRNA-electroporated dendritic cells. Mol Ther 2005;12:922-932.
58. Ghiringhelli F, Menard C, Terme M, et al: CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner. J Exp Med 2005;202:1075-1085.
59. Erdman SE, Sohn JJ, Rao VP, et al: CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res 2005;65:3998-4004.
60. Erdman SE, Rao VP, Poutahidis T, et al: CD4(+) CD25(+) regulatory lymphocytes require interleukin 10 to interrupt colon carcinogenesis in mice. Cancer Res 2003;63:6042-6050.
61. Abraham VS, Sachs DH, Sykes M: Mechanism of protection from graft-versus-host disease mortality by IL-2. III. Early reductions in donor T cell subsets and expansion of a CD3+CD4- CD8- cell population. J Immunol 1992;148:3746-3752.
62. Young KJ, DuTemple B, Zhang Z, Levy G, Zhang L: CD4(-)CD8(-) regulatory T cells implicated in preventing graft-versus-host and promoting graft-versusleukemia responses. Transplant Proc 2001;33:1762-1763.
63. Matsuo R, Herndon DN, Kobayashi M, Pollard RB, Suzuki F: CD4- CD8- TCR alpha/beta+ suppressor T cells demonstrated in mice 1 day after thermal injury. J Trauma 1997;42:635-640.
64. Kadena T, Matsuzaki G, Fujise S, et al: TCR alpha beta+ CD4- CD8- T cells differentiate extrathymically in an lck-independent manner and participate in early response against Listeria monocytogenes infection through interferon-gamma production. Immunology 1997;91:511-519.
65. Hossain MS, Takimoto H, Ninomiya T, et al: Characterization of CD4- CD8- CD3+ T-cell receptor-alphabeta+ T cells in murine cytomegalovirus infection. Immunology 2000;101:19-29.
66. Johansson M, Lycke N: A unique population of extrathymically derived alpha beta TCR+CD4-CD8- T cells with regulatory functions dominates the mouse female genital tract. J Immunol 2003;170:1659-1666.
67. Thornton AM, Shevach EM: Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000;164:183-190.
68. Dai Z, Li Q, Wang Y, et al: CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004;113:310-317.
69. Tanchot C,Vasseur F, Pontoux C, Garcia C, Sarukhan A: Immune regulation by self-reactive T cells is antigen specific. J Immunol 2004;172:4285-4291.
70. Hudrisier D, Riond J, Mazarguil H, Gairin JE, Joly E: Cutting edge: CTLs rapidly capture membrane fragments from target cells in a TCR signaling-dependent manner. J Immunol 2001;166:3645-3649.
71. Stinchcombe JC, Bossi G, Booth S, Griffiths GM: The immunological synapse of CTL contains a secretory domain and membrane bridges. Immunity 2001;15: 751-761.
72. Hwang I, Huang JF, Kishimoto H, et al: T cells can use either T cell receptor or CD28 receptors to absorb and internalize cell surface molecules derived from antigenpresenting cells. J Exp Med 2000;191:1137-1148.
73. Sabzevari H, Kantor J, Jaigirdar A, et al: Acquisition of CD80 (B7-1) by T cells. J Immunol 2001;166: 2505-2513.
74. Patel DM, Arnold PY, White GA, Nardella JP, Mannie MD: Class II MHC/peptide complexes are released from APC and are acquired by T cell responders during specific antigen recognition. J Immunol 1999;163: 5201-5210.
75. Huang JF, Yang Y, Sepulveda H, et al: TCR-Mediated internalization of peptide-MHC complexes acquired by T cells. Science 1999;286:952-954.
76. Tsang JY, Chai JG, Lechler R: Antigen presentation by mouse CD4+ T cells involving acquired MHC class II:peptide complexes: another mechanism to limit clonal expansion? Blood 2003;101:2704-2710.
77. Batista FD, Iber D, Neuberger MS: B cells acquire antigen from target cells after synapse formation. Nature 2001;411:489-494.
78. Harshyne LA,Watkins SC, Gambotto A, Barratt-Boyes, SM: Dendritic cells acquire antigens from live cells for cross-presentation to CTL. J Immunol 2001;166: 3717-3723.
79. Daeron M: Fc receptor biology. Annu Rev Immunol 1997;15:203-234.
80. Koyasu S, D'Adamio L, Arulanandam AR, Abraham S, Clayton LK, Reinherz EL: T cell receptor complexes containing Fc epsilon RI gamma homodimers in lieu of CD3 zeta and CD3 eta components: a novel isoform expressed on large granular lymphocytes. J Exp Med 1992;175:203-209.
81. Green DR, Droin N, Pinkoski M: Activation-induced cell death in T cells. Immunol Rev 2003;193:70-81.
82. Hamad AR, Mohamood AS, Trujillo CJ, Huang CT, Yuan E, Schneck JP: B220+ double-negative T cells suppress polyclonal T cell activation by a Fas-independent mechanism that involves inhibition of IL-2 production. J Immunol 2003;171:2421-2426.
83. Powrie F, Carlino J, Leach MW, Mauze S, Coffman RL: A critical role for transforming growth factor-beta but not interleukin 4 in the suppression of T helper type 1-mediated colitis by CD45RB(low) CD4+ T cells. J Exp Med 1996;183:2669-2674.
84. Asseman C, Mauze S, Leach MW, Coffman RL, Powrie F: An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J Exp Med 1999;190:995-1004.
85. Seddon B, Mason D: Regulatory T cells in the control of autoimmunity: the essential role of transforming growth factor beta and interleukin 4 in the prevention of autoimmune thyroiditis in rats by peripheral CD4(+)CD. J Exp Med 1999;189:279-288.
86. Sawitzki B, Kingsley CI, Oliveira V, Karim M, Herber M, Wood, KJ: IFN-sgamma production by alloantigen-reactive regulatory T cells is important for their regulatory function in vivo. J Exp Med 2005;201:1925-1935.
87. Ansel KM, McHeyzer-Williams LJ, Ngo VN, McHeyzer-Williams MG, Cyster JG: In vivo-activated CD4 T cells upregulate CXC chemokine receptor 5 and reprogram their response to lymphoid chemokines. J Exp Med 1999;190:1123-1134.
88. Khan Q, Penninger JM,Yang L, Marra LE, Kozieradzki I, Zhang L: Regulation of apoptosis in mature alpha-beta+CD4-CD8-antigen-specific suppressor T cell clones. J Immunol 1999;162:5860-5867.
89. Lee BP, Chen W, Shi H, Der SD, Forster R, Zhang L: CXCR5/CXCL13 interaction is important for double-negative T cell homing to cardiac allografts. J Immunol 2006;176:5276-5283.